Physician profile
Eli S Levine
NPI 1457526311
$11,996.47
in general payments reported to CMS, 2019-2025
37 companies · $1,569 in 2025
The $1,569 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,271 · 2020: $501 · 2021: $833 · 2022: $2,213 · 2023: $1,820 · 2024: $2,790 · 2025: $1,569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,178.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,191.53 | 2019-2025 | Aveir, Jot Dx, Ensite |
| Boston Scientific Corporation | $1,946.69 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Bodyguardian, Emblem Mri S-Icd |
| Bard Peripheral Vascular, INC. | $883.15 | 2022-2025 | Venclose Maven Catheter |
| Cardiovascular Systems INC. | $827.24 | 2019-2022 | |
| Cook Medical LLC | $612.26 | 2019-2025 | Zilver Ptx, Icast Covered Stent System, 6mmx22mmx120cm, Zilver Vena |
| Medtronic, INC. | $462.45 | 2021-2025 | Closurefast, Micra, Reveal Linq |
| Pfizer INC. | $338.09 | 2019-2025 | |
| Biotronik INC. | $323.42 | 2019-2023 | Biomonitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $316.55 | 2019-2022 | |
| Atricure, INC. | $307.72 | 2022-2025 | Synergy Ablation System |
| Amarin Pharma, INC. | $306.97 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $303.94 | 2019-2024 | Xarelto |
| Shockwave Medical, INC | $285.60 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $268.10 | 2022 | |
| Novartis Pharmaceuticals Corporation | $218.32 | 2019-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $181.39 | 2019-2020 | |
| Edwards Lifesciences Corporation | $154.81 | 2023 | Mitris Resilia Mitral Valve |
| Astrazeneca Pharmaceuticals LP | $154.31 | 2021-2023 | Wainua |
| Heartflow, INC. | $144.75 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.74 | 2019-2025 | Jardiance |
| Amgen INC. | $84.59 | 2020-2022 | |
| Cvrx, INC. | $82.46 | 2023-2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $72.19 | 2021-2025 | Camzyos |
| Kestra Medical Technology Services, INC. | $57.45 | 2023-2024 | Assure Wcd |
| Cleerly, INC. | $46.23 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Penumbra, INC. | $42.22 | 2021-2023 | Smart Coil |
| Philips North America LLC | $36.30 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Acutus Medical, INC. | $32.30 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $30.40 | 2021-2022 | |
| Tactile Systems Technology INC | $23.30 | 2021 | |
| Becton, Dickinson and Company | $23.06 | 2024 | Venclose Maven Catheter |
| Esperion Therapeutics, INC. | $20.09 | 2024 | Nexletol |
| Novo Nordisk INC | $17.96 | 2024 | Ozempic |
| Vital Connect, INC | $16.75 | 2025 | Vitalpatch Rtm |
| Kiniksa Pharmaceuticals International, Plc | $16.45 | 2024 | Arcalyst |
| Kowa Pharmaceuticals America, INC. | $16.44 | 2021 | |
| Smith+Nephew, INC. | $14.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eli Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.